Erik L Kimble

10PUBLICATIONS

45CO-AUTHORS

Haematological tumoursFuzzy computationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 13, 2026

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

|Jan 14, 2026

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.

Emily C Liang, Yein Jeon, Yang Qiao

|Nov 18, 2025

Novel antibodies for identification, selection, and manipulation of T cells expressing Whitlow linker-containing CARs.

Erik L Kimble, Jocelyn H Wright, Aiko Torkelson

|Dec 03, 2024

Development and validation of predictive models of early immune effector cell-associated hematotoxicity.

Emily C Liang, Jennifer J Huang, Andrew J Portuguese

|Sep 27, 2024

Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.

S Fiorenza, Y Zheng, J Purushe

|Jun 06, 2024

qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue.

Shalini Pullarkat, Graeme Black, Marie Bleakley

Pageof 2

Frequent Collaborators

Alexandre V Hirayama

Jordan Gauthier

Mazyar Shadman

Jennifer J Huang

Andrew J Portuguese

Emily C Liang

Salvatore Fiorenza

Aude G Chapuis

Qian Wu

Ryan D Cassaday

Frequent Collaborators

Alexandre V Hirayama

Jordan Gauthier

Mazyar Shadman

Jennifer J Huang